Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
GeoVax

GeoVax

A biotechnology company developing human vaccines against infectious diseases and cancers. It was founded in 2001 and is located in Smyrna, Georgia.

GeoVax is a Georgia-based clinical-stage biotechnology company with a focus on researching and developing vaccines for illnesses including HIV, Ebola, HBV, HPV, and for cancer immunotherapy. The company designs its programs around a novel platform that integrates its recombinant Modified Vaccinia Ankara (MVA) vector technology with antigen design and manufacturing technologies.

COVID-19

In 2020, the company partnered with BravoVax, a Chinese pharmaceutical testing and manufacturing company. GeoVax had been conducting research for a vaccine for COVID-19 and developed three vaccine candidates. The company stated that it would narrow it down to one candidate and upon approval, commence animal studies with the vaccine.

Timeline

September 2018
GeoVax raises a $2,400,000 grant.
2008
GeoVax was founded by David A. Dodd and Harriet L. Robinson.

Funding rounds

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Cobb company to soon begin testing possible vaccines for COVID-19

Web

GeoVax Progresses in Coronavirus (COVID-19) Vaccine Development Program

GeoVax, Inc.

Web

March 18, 2020

References

Golden logo
By using this site, you agree to our Terms & Conditions.